How does the Patent Cooperation Treaty (PCT) affect foreign priority claims?

The Patent Cooperation Treaty (PCT) interacts with foreign priority claims as outlined in MPEP 213. The PCT allows applicants to file a single international patent application that can later enter the national phase in multiple countries. Key points regarding PCT and foreign priority: PCT applications can claim priority from earlier national or regional applications The…

Read More

Which countries are recognized for priority claims under 35 U.S.C. 119(a)-(d)?

The MPEP provides a table of states (countries) for which the right of priority under 35 U.S.C. 119(a)-(d) is recognized. These countries fall into three categories: Parties to the Patent Cooperation Treaty (PCT) Parties to the Paris Convention for the Protection of Industrial Property Members of the World Trade Organization (WTO) The MPEP states: “Following…

Read More

What are the requirements for claiming the benefit of an international application?

Claiming the benefit of an international application (PCT application) in a U.S. national application has specific requirements. The MPEP states: “Pursuant to 35 U.S.C. 365(c), a regular national application filed under 35 U.S.C. 111(a) and 37 CFR 1.53(b) may claim the benefit of the filing date of an international application which designates the United States…

Read More

What is the significance of the ‘365(c)’ filing date in claiming benefit of a nonprovisional application?

What is the significance of the ‘365(c)’ filing date in claiming benefit of a nonprovisional application? The ‘365(c)’ filing date is crucial when claiming the benefit of a nonprovisional application that was filed as a PCT application and entered the national stage. According to MPEP 211.01(b): ‘If the prior nonprovisional application is an international application…

Read More

Why does MPEP 602.07 refer to MPEP § 1893.01(e)?

MPEP 602.07 refers to MPEP § 1893.01(e) because the latter section provides more detailed information about oaths or declarations filed in the United States as a designated office. The full text of MPEP 602.07 states: See MPEP § 1893.01(e). This reference indicates that MPEP § 1893.01(e) contains comprehensive guidance on the requirements, procedures, and considerations…

Read More

What is MPEP 602.07 about?

MPEP 602.07 is titled ‘Oath or Declaration Filed in United States as a Designated Office’. This section provides guidance on the requirements for oaths or declarations filed in the United States Patent and Trademark Office (USPTO) when it acts as a designated office for international patent applications under the Patent Cooperation Treaty (PCT). The section…

Read More

How should applicants handle status inquiries for PCT applications?

For status inquiries regarding PCT applications, the MPEP provides specific guidance: Inquiries relating to international applications filed under the Patent Cooperation Treaty (PCT) should be directed to the PCT Help Desk. The MPEP states: Inquiries relating to international applications (PCT) … should be directed to the PCT Help Desk at 1-800-PTO-9199 or 571-272-4300. The PCT…

Read More

How does the priority claim deadline differ for PCT applications entering the national stage in the U.S.?

The priority claim deadline for PCT applications entering the national stage in the U.S. differs from that of regular U.S. patent applications: PCT National Stage Applications: For these applications, the priority claim must be made within the time limit set in the PCT and the Regulations under the PCT. Regular U.S. Applications: The deadline is…

Read More

How does PDX handle international applications filed under the PCT?

The PDX system has specific procedures for handling international applications filed under the Patent Cooperation Treaty (PCT). According to MPEP 215.01: The USPTO will automatically attempt retrieval of international applications filed under the PCT where the receiving office is RO/AU, RO/DK, RO/ES, RO/FI, RO/IB, RO/MA or RO/SE and the applicant has provided the required WIPO…

Read More